(PharmaNewsWire.Com, July 05, 2017 ) According to Publisher, the Global Newborn Screening market is accounted for $495.50 million in 2015 and is expected to reach $1,307.65 million by 2022 growing at a CAGR of 12.9%. In present scenario the Newborn baby is either being affected by the environmental conditions or born with some disorder, and hence the Newborn Screening market is helping out to detect those disorders. Recent technological advancements, government legislation & support, increasing awareness among people have given impetus to the market. However, Socio-Economic barriers and less trained professionals are some of the factors hindering the growth.
Tandem Mass Spectrometry (TMS) segment is expected to account for highest CAGR, attributing to its time & cost effectiveness of the technology compared to other technologies available in this particular market. In addition to this, Dry Blood Spot Test type segment is expected to be the largest market owing to the technological advancements due to which new and advanced products are being launched in the market. North America is dominating the global market in order to the increasing prevalence of cardiovascular disorders and enforced testing. However, Asia Pacific is expected to present lenient growth, poised by the favorable healthcare.
Some of the key players of the Newborn Screening market include AB Sciex LLC, Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Covidien PLC, GE Healthcare, GE Lifesciences, Masimo Corporation, Natus Medical Incorporated, Perkinelmer, Inc., Trivitron Healthcare and Waters Corporation.
Product types Covered: - Newborn Hearing Screening Instruments o Hearing Screening Accessories o Hearing Screening Devices - Pulse Oximeters - Newborn Disorder Screening Instruments o Developmental o Genetic o Metabolic - Reagents and Assay Kits
Technologies Covered: - DNA-Based Assays - Electrophoresis - Hearing Screen Technology - Immunoassays and Enzymatic Assays - Pulse Oximetry Screening Technology - Tandem Mass Spectrometry (TMS)
Test Types Covered: - Critical Congenital Heart Diseases (CCHD) Test - Dry Blood Spot Test - Hearing Screen Test
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
10 Company Profiling 10.1 AB Sciex LLC 10.2 Agilent Technologies Inc. 10.3 Bio-Rad Laboratories, Inc. 10.4 Covidien PLC 10.5 GE Healthcare 10.6 GE Lifesciences 10.7 Masimo Corporation 10.8 Natus Medical Incorporated 10.9 Perkinelmer, Inc. 10.10 Trivitron Healthcare 10.11 Waters Corporation
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
